News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
62,064 Results
Type
Article (1538)
Company Profile (16)
Press Release (60510)
Section
Business (29687)
Career Advice (35)
Deals (4408)
Drug Delivery (4)
Drug Development (6799)
Employer Resources (8)
FDA (1106)
Job Trends (1643)
News (39994)
Policy (2013)
Tag
Academia (133)
Adcomms (1)
Allergies (9)
Alliances (2150)
ALS (8)
Alzheimer's disease (142)
Antibody-drug conjugate (ADC) (8)
Approvals (1141)
Artificial intelligence (11)
Automation (2)
Bankruptcy (13)
Best Places to Work (1573)
Biosimilars (3)
Biotechnology (9)
Bladder cancer (19)
Brain cancer (2)
Breast cancer (54)
Cancer (299)
Cardiovascular disease (18)
Career advice (34)
Career pathing (1)
CAR-T (7)
Cell therapy (23)
Cervical cancer (5)
Clinical research (6080)
Collaboration (34)
Compensation (35)
COVID-19 (149)
CRISPR (2)
C-suite (9)
Cystic fibrosis (10)
Data (361)
Depression (3)
Diabetes (16)
Diagnostics (681)
Digital health (3)
Diversity, equity & inclusion (2)
Drug discovery (6)
Drug pricing (3)
Duchenne muscular dystrophy (8)
Earnings (26881)
Editorial (2)
Employer branding (2)
Employer resources (8)
Events (6675)
Executive appointments (16)
FDA (1301)
Frontotemporal dementia (1)
Funding (38)
Gene editing (3)
Generative AI (1)
Gene therapy (23)
GLP-1 (50)
Government (237)
Grass and pollen (1)
Guidances (92)
Healthcare (1987)
IgA nephropathy (7)
Immunology and inflammation (10)
Indications (3)
Infectious disease (161)
Inflammatory bowel disease (12)
Influenza (3)
Intellectual property (4)
Interviews (2)
IPO (3429)
Job creations (174)
Job search strategy (31)
Kidney cancer (1)
Labor market (2)
Layoffs (28)
Legal (347)
Liver cancer (3)
Lung cancer (53)
Lymphoma (33)
Management (3)
Manufacturing (12)
MASH (10)
Medical device (1493)
Medtech (1493)
Mergers & acquisitions (1036)
Metabolic disorders (52)
Multiple sclerosis (12)
NASH (3)
Neurodegenerative disease (6)
Neuroscience (191)
NextGen: Class of 2025 (448)
Non-profit (219)
Now hiring (1)
Obesity (25)
Opinion (5)
Ovarian cancer (9)
Pain (6)
Pancreatic cancer (7)
Parkinson's disease (14)
Patents (13)
Patient recruitment (7)
Peanut (5)
People (1685)
Pharmaceutical (4)
Pharmacy benefit managers (1)
Phase I (1427)
Phase II (2495)
Phase III (2550)
Pipeline (534)
Policy (2)
Postmarket research (276)
Preclinical (461)
Press Release (1)
Prostate cancer (14)
Radiopharmaceuticals (27)
Rare diseases (36)
Real estate (246)
Recruiting (4)
Regulatory (1591)
Reports (13)
Research institute (161)
Resumes & cover letters (2)
RSV (6)
Schizophrenia (8)
Series A (4)
Series B (4)
Service/supplier (1)
Sickle cell disease (3)
Special edition (1)
Spinal muscular atrophy (8)
Sponsored (1)
Startups (131)
Stomach cancer (1)
Supply chain (5)
Tariffs (4)
Vaccines (32)
Venture capitalists (4)
Weight loss (12)
Women's health (1)
Date
Today (34)
Last 7 days (233)
Last 30 days (479)
Last 365 days (4619)
2025 (1747)
2024 (4797)
2023 (5244)
2022 (6017)
2021 (6399)
2020 (5199)
2019 (4230)
2018 (3435)
2017 (2899)
2016 (2042)
2015 (3195)
2014 (2189)
2013 (1384)
2012 (1580)
2011 (1709)
2010 (1584)
Location
Africa (30)
Alabama (4)
Alaska (1)
Arizona (11)
Arkansas (1)
Asia (3141)
Australia (545)
California (820)
Canada (331)
China (42)
Colorado (40)
Connecticut (34)
Delaware (42)
Europe (8499)
Florida (93)
Georgia (42)
Idaho (2)
Illinois (64)
India (1)
Indiana (56)
Japan (18)
Kansas (8)
Kentucky (3)
Louisiana (4)
Maine (11)
Maryland (108)
Massachusetts (603)
Michigan (37)
Minnesota (56)
Missouri (13)
Montana (3)
Nevada (6)
New Hampshire (10)
New Jersey (273)
New York (233)
North Carolina (119)
Northern California (403)
Ohio (12)
Oregon (1)
Pennsylvania (208)
Rhode Island (1)
South America (70)
Southern California (329)
Tennessee (6)
Texas (88)
United States (3109)
Utah (30)
Virginia (26)
Washington D.C. (14)
Washington State (99)
Wisconsin (3)
62,064 Results for "63".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Johnson & Johnson Announces 63rd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.8%
April 15, 2025
·
1 min read
Press Releases
U.S. Biosensors Market Size to Surpass USD 19.63 Billion by 2033
February 26, 2025
·
1 min read
Press Releases
Molecular Diagnostics Market Size Forecasted to Hit USD 63.86 Bn By 2034
February 19, 2025
·
1 min read
Press Releases
DNA Sequencing Market Size Leads by 21.69% Healthy CAGR to Hit $107.63 Billion by 203
February 10, 2025
·
1 min read
Press Releases
Cardiotoxicity Market Size to Reach USD 948.63 Million by 2035, Impelled by Surge in Heart Disease Incidents
February 14, 2025
·
7 min read
Drug Development
IGC Pharma’s TGR-63 Preclinical Results Show Substantial Reduction in Amyloid Plaque, a Key Hallmark of Alzheimer’s Disease
IGC Pharma, Inc. (NYSE American: IGC) (“IGC” or the “Company”) today announced encouraging preclinical results in an Alzheimer’s mouse model demonstrating the potential of the Company’s therapeutic candidate, TGR-63, to combat Alzheimer’s disease.
June 25, 2024
·
4 min read
BioCapital
Promising Results: TGR-63 Enhances Memory in Alzheimer’s Mouse Model
IGC Pharma, Inc. announced the results of preclinical studies investigating its drug candidate TGR-63 as a treatment for Alzheimer’s disease.
February 28, 2024
·
5 min read
Press Releases
Alto Neuroscience Announces Data Presented at the 63rd Annual Meeting of the American College of Neuropsychopharmacology
December 11, 2024
·
8 min read
Pharm Country
Neurosterix launches with $63M to Advance Allosteric Modulator Therapeutics for Neurological Disorders
Neurosterix, a biopharmaceutical company dedicated to the development of allosteric modulator therapeutics for underserved neurological disorders, launched with a $63 million Series A financing led by Perceptive Xontogeny Venture Fund II, with participation from Perceptive Life Sciences Fund and Acorn Bioventures.
April 3, 2024
·
5 min read
Press Releases
Arcutis Announces Preliminary Unaudited Fourth Quarter Product Revenue and Full-Year 2024 Product Revenues of Approximately $63 Million and $160 Million
January 13, 2025
·
6 min read
1 of 6,207
Next
